NO20010469L - Antidiabetiske piperazinderivater, fremgangsmåter for deres fremstilling og preparater inneholdende dem - Google Patents
Antidiabetiske piperazinderivater, fremgangsmåter for deres fremstilling og preparater inneholdende demInfo
- Publication number
- NO20010469L NO20010469L NO20010469A NO20010469A NO20010469L NO 20010469 L NO20010469 L NO 20010469L NO 20010469 A NO20010469 A NO 20010469A NO 20010469 A NO20010469 A NO 20010469A NO 20010469 L NO20010469 L NO 20010469L
- Authority
- NO
- Norway
- Prior art keywords
- antidiabetic
- processes
- preparation
- preparations containing
- piperazine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9809660A FR2781797B1 (fr) | 1998-07-28 | 1998-07-28 | Derives de piperazine antidiabetiques, leurs procedes de preparation et compositions pharmaceutiques les contenant |
| PCT/EP1999/005111 WO2000006558A1 (fr) | 1998-07-28 | 1999-07-17 | Derives antidiabetiques de piperazine, leurs procedes de preparation et compositions les contenant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20010469D0 NO20010469D0 (no) | 2001-01-26 |
| NO20010469L true NO20010469L (no) | 2001-01-26 |
Family
ID=9529125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20010469A NO20010469L (no) | 1998-07-28 | 2001-01-26 | Antidiabetiske piperazinderivater, fremgangsmåter for deres fremstilling og preparater inneholdende dem |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US6376495B1 (fr) |
| EP (1) | EP1100790A1 (fr) |
| JP (1) | JP2002521477A (fr) |
| KR (1) | KR20010072775A (fr) |
| AR (1) | AR020646A1 (fr) |
| AU (1) | AU752993B2 (fr) |
| BR (1) | BR9913149A (fr) |
| CA (1) | CA2338694A1 (fr) |
| FR (1) | FR2781797B1 (fr) |
| HU (1) | HUP0102830A3 (fr) |
| NO (1) | NO20010469L (fr) |
| PL (1) | PL345735A1 (fr) |
| RU (1) | RU2208610C2 (fr) |
| SK (1) | SK1142001A3 (fr) |
| TW (1) | TW472046B (fr) |
| WO (1) | WO2000006558A1 (fr) |
| ZA (1) | ZA200102495B (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2372715A1 (fr) * | 1999-05-13 | 2001-04-12 | Shionogi & Co., Ltd. | Principes actifs destines au soin ou a la prevention de diabetes |
| FR2829765A1 (fr) * | 2001-09-14 | 2003-03-21 | Lipha | Derives imidazolylalkoxylarylalcanoiques leurs applications en therapeutique |
| AU2006282403B2 (en) | 2005-08-26 | 2011-07-07 | Institute Of Medicinal Molecular Design, Inc. | Derivative having PPAR agonistic activity |
| JP2008239616A (ja) * | 2007-02-28 | 2008-10-09 | Iyaku Bunshi Sekkei Kenkyusho:Kk | Ｈｄｌ上昇剤 |
| CN102485717B (zh) | 2010-12-06 | 2015-12-02 | 中国人民解放军军事医学科学院毒物药物研究所 | 噻唑胺衍生物及其作为抗小rna病毒感染药物的用途 |
| FR2976943B1 (fr) * | 2011-06-23 | 2013-07-12 | Metabolys | Derives de piperazine, leurs procedes de preparation et leurs utilisations dans le traitement de l'insulinoresistance |
| FR2976942B1 (fr) * | 2011-06-23 | 2013-07-12 | Metabolys | Derives de piperazine, leurs procedes de preparation et leurs utilisations dans le traitement de l'insulinoresistance |
| FR2999427B1 (fr) | 2012-12-17 | 2015-01-30 | Metabolys | Composition et kit comprenant des derives de piperazine et de la metformine, leur utilisation dans le traitement du diabete |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3277094A (en) * | 1965-05-10 | 1966-10-04 | Ciba Geigy Corp | Piperazine derivatives |
| US3951983A (en) * | 1970-11-10 | 1976-04-20 | Pfizer Inc. | Phenoxypropanolpiperazines |
| DE3564683D1 (en) * | 1984-08-07 | 1988-10-06 | Cortial | 4-(arylpiperazinylethylaminoethoxy) phenol derivatives, process for their preparation and their therapeutical application |
| US5464788A (en) * | 1994-03-24 | 1995-11-07 | Merck & Co., Inc. | Tocolytic oxytocin receptor antagonists |
-
1998
- 1998-07-28 FR FR9809660A patent/FR2781797B1/fr not_active Expired - Fee Related
-
1999
- 1999-07-17 JP JP2000562361A patent/JP2002521477A/ja active Pending
- 1999-07-17 SK SK114-2001A patent/SK1142001A3/sk unknown
- 1999-07-17 US US09/744,693 patent/US6376495B1/en not_active Expired - Fee Related
- 1999-07-17 AU AU51609/99A patent/AU752993B2/en not_active Ceased
- 1999-07-17 WO PCT/EP1999/005111 patent/WO2000006558A1/fr not_active Application Discontinuation
- 1999-07-17 EP EP99936561A patent/EP1100790A1/fr not_active Withdrawn
- 1999-07-17 BR BR9913149-8A patent/BR9913149A/pt not_active IP Right Cessation
- 1999-07-17 KR KR1020017002107A patent/KR20010072775A/ko not_active Application Discontinuation
- 1999-07-17 CA CA002338694A patent/CA2338694A1/fr not_active Abandoned
- 1999-07-17 HU HU0102830A patent/HUP0102830A3/hu unknown
- 1999-07-17 RU RU2001104880/04A patent/RU2208610C2/ru not_active IP Right Cessation
- 1999-07-17 PL PL99345735A patent/PL345735A1/xx unknown
- 1999-07-28 AR ARP990103735A patent/AR020646A1/es not_active Application Discontinuation
- 1999-09-23 TW TW088112795A patent/TW472046B/zh not_active IP Right Cessation
-
2001
- 2001-01-26 NO NO20010469A patent/NO20010469L/no not_active Application Discontinuation
- 2001-03-27 ZA ZA200102495A patent/ZA200102495B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2208610C2 (ru) | 2003-07-20 |
| NO20010469D0 (no) | 2001-01-26 |
| CA2338694A1 (fr) | 2000-02-10 |
| PL345735A1 (en) | 2002-01-02 |
| SK1142001A3 (en) | 2001-09-11 |
| HUP0102830A3 (en) | 2002-12-28 |
| US6376495B1 (en) | 2002-04-23 |
| FR2781797B1 (fr) | 2000-11-03 |
| AU752993B2 (en) | 2002-10-03 |
| EP1100790A1 (fr) | 2001-05-23 |
| HUP0102830A2 (hu) | 2001-12-28 |
| ZA200102495B (en) | 2002-09-27 |
| WO2000006558A1 (fr) | 2000-02-10 |
| BR9913149A (pt) | 2003-01-21 |
| KR20010072775A (ko) | 2001-07-31 |
| AU5160999A (en) | 2000-02-21 |
| AR020646A1 (es) | 2002-05-22 |
| FR2781797A1 (fr) | 2000-02-04 |
| JP2002521477A (ja) | 2002-07-16 |
| TW472046B (en) | 2002-01-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1337529T3 (da) | Heterocyclylalkylpiperidinderivater, deres fremstilling og præparater indeholdende dem | |
| NO20011216L (no) | Azetidinderivater, deres fremstilling og medikamenter inneholdende forbindelsene | |
| DK0676409T3 (da) | Erythromycinderivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler | |
| NO20012058L (no) | 2-ureido-tiazolderivater, fremgangsmåte for deres fremstilling og anvendelse som antitumormidler | |
| DK1202733T3 (da) | 3(5)-amino-pyrazolderivater, fremgangsmåde til deres fremstilling og deres anvendelse som antitumormidler | |
| NO20001409D0 (no) | Karboksamidotiazolderivater, fremgangsmåte for fremstilling derav og farmasøytiske blandinger | |
| DK0740668T3 (da) | Tetracykliske derivater, fremgangsmåde til deres fremstilling og deres anvendelse | |
| NO20014013D0 (no) | 16-halogenepotilonderivater, fremgangsmater for fremstilling av dem og deres farmasoytiske anvendelse | |
| NO20012057D0 (no) | 2-amino-tiazolderivater, fremgangsmåte for deres fremstilling og anvendelse som antitumormidler | |
| DK1112251T3 (da) | Azetidinderivater, deres fremstilling og medikamenter indeholdende disse derivater | |
| NO993003L (no) | Sulfonamid-derivater, fremgangsmÕte for deres fremstilling og deres anvendelse som medikamenter | |
| NO20006251D0 (no) | Benzotiepin-1,1-dioksidderivater, fremgangsmåte for deres fremstilling, legemidler som inneholder disse forbindelsene og deres anvendelse | |
| NO20024175D0 (no) | Azetidinderivater, deres fremstilling og farmasöytiske forbindelser inneholdende de samme | |
| DK0985697T3 (da) | Oxiranderivater og fremgangsmåde til fremstilling deraf | |
| NO964654L (no) | Nye erytromycinderivater, fremgangsmåte for deres fremstilling og deres anvendelse som legemidler | |
| NO972881D0 (no) | Piperazinderivater, legemidler som inneholder disse, anvendelse derav og fremgangsmåte for deres fremstilling | |
| NO985368L (no) | Substituerte imidazolidinderivater, deres fremstilling, deres anvendelse og farmas°ytiske preparater inneholdende forbindelsene | |
| DK1370550T3 (da) | Quinolylpropylpiperidinderivater, deres fremstilling og præparater indeholdende dem | |
| NO20005146L (no) | Tienylazolylalkoksyetanaminer, deres fremstilling og deres anvendelse som medikamenter | |
| NO985671D0 (no) | Nye Tiazolidindion-2-derivater som er 4-diketonsubstituerte, fremgangsmÕte for deres fremstilling og farmas°ytiske preparater som inneholder dem | |
| DK0912509T3 (da) | Distamycinderivater, fremgangsmåde til fremstilling deraf og deres anvendelse som antitumor- og antivirale midler | |
| DK0903339T3 (da) | Biphenylsulfonylcyanamid, fremgangsmåde til deres fremstilling og deres anvendelse som medikament | |
| NO20016247D0 (no) | Streptograminderivater, deres fremstilling og preparater inneholdende derivatene | |
| NO20010469D0 (no) | Antidiabetiske piperazinderivater, fremgangsmåter for deres fremstilling og preparater inneholdende dem | |
| NO20010219L (no) | Polycykliske tiazolidin-2-ylidenaminer, fremgangsmÕte for deres fremstilling og deres anvendelse som legemiddel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |